Literature DB >> 14571616

[Effect of dihydro-qinghaosu on auto-antibody production, TNF alpha secretion and pathologic change of lupus nephritis in BXSB mice].

Yan-jun Dong1, Wei-dong Li, You-you Tu.   

Abstract

OBJECTIVE: To investigate the effect of dihydro-qinghaosu (DQHS) on auto-antibody production, TNF alpha secretion and pathologic change of lupus nephritis in BXSB mice and the possible mechanism of DQHS in treating systemic lupus erythematosus (SLE).
METHODS: Anti ds-DNA antibody and TNF alpha in serum of the BXSB mice were detected by enzyme linked immunosorbent assay (ELISA). Renal tissue was stained by HE and Masson.
RESULTS: In the height and moderate dose DQHS groups, as compared with the model group, levels of anti-ds-DNA antibody and serum TNF alpha were significantly lower (P < 0.05); and renal pathological change was milder.
CONCLUSION: DQHS could inhibit the production of anti-ds-DNA antibody and secretion of TNF alpha and improve the pathologic lesion of lupus nephritis in BXSB mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14571616

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  10 in total

1.  The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine.

Authors:  Youyou Tu
Journal:  Nat Med       Date:  2011-10-11       Impact factor: 53.440

Review 2.  Immune suppressive properties of artemisinin family drugs.

Authors:  Lifei Hou; Haochu Huang
Journal:  Pharmacol Ther       Date:  2016-07-10       Impact factor: 12.310

3.  Dihydroartemisinin-induced apoptosis in human acute monocytic leukemia cells.

Authors:  Jia-Tian Cao; Hui-Min Mo; Yue Wang; Kai Zhao; Tian-Tian Zhang; Chang-Qian Wang; Kai-Lin Xu; Zhi-Hua Han
Journal:  Oncol Lett       Date:  2017-12-19       Impact factor: 2.967

Review 4.  Artemisinins-a Promising New Treatment for Systemic Lupus Erythematosus: a Descriptive Review.

Authors:  Xiaozhen Mu; Chenchen Wang
Journal:  Curr Rheumatol Rep       Date:  2018-07-28       Impact factor: 4.592

5.  SM905, an artemisinin derivative, inhibited NO and pro-inflammatory cytokine production by suppressing MAPK and NF-kappaB pathways in RAW 264.7 macrophages.

Authors:  Jun-Xia Wang; Li-Fei Hou; Yang Yang; Wei Tang; Ying Li; Jian-Ping Zuo
Journal:  Acta Pharmacol Sin       Date:  2009-10       Impact factor: 6.150

6.  The new water-soluble artemisinin derivative SM905 ameliorates collagen-induced arthritis by suppression of inflammatory and Th17 responses.

Authors:  J-X Wang; W Tang; R Zhou; J Wan; L-P Shi; Y Zhang; Y-F Yang; Y Li; J-P Zuo
Journal:  Br J Pharmacol       Date:  2008-02-11       Impact factor: 8.739

7.  Artemisinin Attenuates Transplant Rejection by Inhibiting Multiple Lymphocytes and Prolongs Cardiac Allograft Survival.

Authors:  Zhe Yang; Fei Han; Tao Liao; Haofeng Zheng; Zihuan Luo; Maolin Ma; Jiannan He; Lei Li; Yongrong Ye; Rui Zhang; Zhengyu Huang; Yannan Zhang; Qiquan Sun
Journal:  Front Immunol       Date:  2021-02-24       Impact factor: 7.561

8.  Dihydroartemisinin attenuates osteoclast formation and bone resorption via inhibiting the NF‑κB, MAPK and NFATc1 signaling pathways and alleviates osteoarthritis.

Authors:  Dong Ding; Jiangbo Yan; Gangning Feng; Yong Zhou; Long Ma; Qunhua Jin
Journal:  Int J Mol Med       Date:  2021-11-05       Impact factor: 4.101

Review 9.  Artemisinins: their growing importance in medicine.

Authors:  Sanjeev Krishna; Leyla Bustamante; Richard K Haynes; Henry M Staines
Journal:  Trends Pharmacol Sci       Date:  2008-08-25       Impact factor: 14.819

10.  Dihydroartemisinin ameliorates psoriatic skin inflammation and its relapse by diminishing CD8+ T-cell memory in wild-type and humanized mice.

Authors:  Yuchao Chen; Yuhong Yan; Huazhen Liu; Feifei Qiu; Chun-Ling Liang; Qunfang Zhang; Run-Yue Huang; Ling Han; Chuanjian Lu; Zhenhua Dai
Journal:  Theranostics       Date:  2020-08-21       Impact factor: 11.556

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.